Johnson & Johnson Share Buyback Likely, Jonas Says

Play

April 18 (Bloomberg) -- Jeff Jonas, an analyst at Gabelli & Co., talks about the impact of debate over the Obama administration's health-care overhaul on health-care stocks, and his assessment of Johnson & Johnson and Abbott Laboratories. He speaks with Tom Keene on Bloomberg Television's "Surveillance Midday." (Source: Bloomberg)